BIOMAT Database Logo BIOMAT Database Logo

[Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations]. 1970

A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva

UI MeSH Term Description Entries
D007539 Isonicotinic Acids Heterocyclic acids that are derivatives of 4-pyridinecarboxylic acid (isonicotinic acid). Isonicotinic Acid,Acid, Isonicotinic,Acids, Isonicotinic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005000 Ethionamide A second-line antitubercular agent that inhibits mycolic acid synthesis. Amidazine,Ethioniamide,Trecator,Trecator-SC,Trecator SC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[The treatment of patients with destructive pulmonary tuberculosis with indomethacin and tuberculostatic preparations].
May 1990, Vrachebnoe delo,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[TREATMENT OF CHRONIC DESTRUCTIVE TUBERCULOSIS OF THE LUNGS WITH TUBERCULOSTATIC PREPARATIONS OF THE 2D SERIES].
January 1963, Problemy tuberkuleza,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[The treatment of pulmonary tuberculosis with intravenous injections of tuberculostatic preparations].
April 1967, Vrachebnoe delo,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Treatment of chronic destructive pulmonary tuberculosis with iontophoresis].
June 1956, Minerva medica,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Treatment of pulmonary tuberculosis by the intravenous infusion of tuberculostatic preparations].
February 1974, Voenno-meditsinskii zhurnal,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Tolerance for second-line preparations in the treatment of chronic destructive pulmonary tuberculosis].
January 1973, Problemy tuberkuleza,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
January 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Late results in the tuberculostatic treatment of pulmonary tuberculosis].
March 1959, Der Tuberkulosearzt,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Results of the treatment and dispensary observation of patients with chronic destructive pulmonary tuberculosis].
January 1973, Problemy tuberkuleza,
A E Rabukhin, and V M Alekseeva, and E S Ivanova, and V F Kubyshkina, and E A Kliuchareva
[Remote results of treatment of patients with destructive pulmonary tuberculosis].
January 1974, Problemy tuberkuleza,
Copied contents to your clipboard!